Bronchodilator Reversibility
BDR
Description
"Bronchodilator Reversibility" test evaluates how well your lungs respond to medication that opens the airways. It’s often used to distinguish between asthma and chronic obstructive pulmonary disease (COPD). You’ll perform a spirometry test before and after using a bronchodilator. If lung function improves, it typically suggests asthma. Doctors use the results to refine diagnoses and adjust treatment strategies. Regular monitoring supports better respiratory care and helps track how well your lungs respond to ongoing treatment.
Category
Lung Function
Procedure
Non-Invasive
Sample Type
Breath
Units
Not Applicable
Procedure Category
Measure
Test Group
Complete Pulmonary Function Group, Physical Function Group
Test Group Description
Complete Pulmonary Function Group: Comprehensive evaluations of respiratory function offer detailed insights into lung function, airway inflammation, and structural abnormalities, facilitating the precise diagnosis and management of pulmonary conditions. Physical Function Group: Tests within this group assess various aspects of physical function, offering insights into an individual's mobility, strength, and endurance. These tests help evaluate overall physical health and identify potential limitations or areas for improvement.
Optimal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Normal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Asthma (chronic inflammatory airway condition)
Chronic obstructive pulmonary disease (progressive lung disease)
Chronic bronchitis (long-term inflammation of bronchial tubes)
Emphysema (damage to air sacs in the lungs)
Bronchiectasis (abnormal widening of bronchial tubes)
Bronchiolitis (inflammation of small airways)
Allergic bronchopulmonary aspergillosis (fungal lung infection)
Cystic fibrosis (genetic disorder affecting lungs and other organs)
Pulmonary fibrosis (scarring of lung tissue)
Respiratory tract infections (such as bronchitis or pneumonia)
Key Reasons For Testing
Diagnosis of Asthma: Confirms asthma by measuring lung function improvement after bronchodilator use.
Differentiation of Asthma from COPD: Identifies whether airflow issues are due to asthma or COPD based on response to bronchodilators.
Treatment Planning: Guides therapy by assessing how airways respond to bronchodilators or other medications.
Monitoring Disease Progression: Tracks changes in airway function over time to evaluate condition management.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
[2] Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing—1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309-329.
[3] Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543-1554.
[4] O’Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008;15(Suppl A):1A-8A.
[5] Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555.
[6] Gibson PG, Wlodarczyk J, Hensley MJ, et al. Epidemiological association of airway hyperresponsiveness and asthma with smoking status in high school students. BMJ. 1996;312(7035):1257-1261.
[7] Quanjer PH, Weiner DJ, Pretto JJ, et al. Measurement of FEV1/FVC ratio in diagnosing airway obstruction. Eur Respir J. 2012;39(1):53-60.
[8] Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
[9] Park HY, Lee SY, Kang JY, et al. Clinical utility of bronchodilator reversibility testing in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul). 2012;73(2):66-74.
[10] Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659-664.
[11] Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting reversible airway obstruction in asthma and COPD? Chest. 1999;115(3):602-607.